Engage Agro USA to distribute Heads Up bean “vaccine”
Engage Agro USA announced it signed a distribution agreement with Heads Up Plant Protectants, Inc. of Saskatoon, Canada, to market Heads Up, a patented and EPA registered pre-plant seed and pre-transplant seedling treatment for edible beans and soybeans.
Heads Up is a unique seed treatment based upon saponin extracts from the new health craze plant, Quinoa. It provides a low cost plant health insurance and vaccine program via Systemic Acquired Resistance (SAR) that triggers the plant’s naturally occurring defense pathways. It is compatible with traditional seed treatment and inoculants.
Heads Up fits perfectly within Engage Agro USA’s product portfolio. Heads Up not only performs in the field, but it has a strong ROI as a result of the cost to the grower being less than $2.50/acre, dependent on seeding rate. In addition, it is an excellent tool, backed up with significant research results, to fight diseases including Sudden Death Syndrome (Fusarium virguliforme), Root Rot/Damping Off (Rhizoctonia solani) and White Mold (Sclerotinia sclerotiorum). In addition, Heads Up is OMRI listed providing an excellent defense for organic farmers.
"It's all about results," says Trevor Thorley, President of Engage Agro USA. “A product can be unique, practical and easy to use, but if it doesn’t perform, we won’t carry it in our line. We are very pleased to offer Heads Up.”
- China adopts stricter pesticide residue standard
- Researchers target soybean disease with genetic resistance study
- K-State Cropping Systems Field Day Set Aug. 28 in Garden City
- Ag markets ended the week in mixed fashion
- Ag turned decidedly mixed Friday morning
- Fall armyworm moth capture sees big jump
- Don’t link bird decline and use of neonicotinoids
- Solar energy jobs increase, wind power decrease
- Comments end for Enlist Duo but not the fight
- Setting the record straight on 'Waters of the U.S.'
- Commentary: Setting the record straight on 'Waters of the U.S.'
- Look at fertilizer pricing 2013 vs. 2014